Regardless the white-anting there is obvious opportunity here - or there would be silence no one would waste their time promoting or trying to discredit for a cheaper entry!
the fact that some find a reason to comment day after day whilst claiming not to hold says all it needs to
- that and the multiple esteemed collaborations with industry heavy weights who are happily continuing on with their investments in our compound through their self-funded trials shows the level of true interest here
it irks some that after years of predictions of doom and gloom we are now reporting more favourable results and as stated today....
In addition to this phase II study in glioblastoma, four other studies are underway with paxalisib in different forms of brain cancer, and it is anticipated that several of these will provide initial efficacy data during CY 2020
four studies for free! Which some posters valued at approx 10-20 million per study as they still do today predicting massive costs and massive dilution... we get the unheard of situation whereby four esteemed research bonfire are so besotted with our compound and it’s potential benefits to patients they spend their hard earned proving our compound works
yes that’s right - it’s literally that big of a game changer for brain cancers.
